An HPLC (High-Performance Liquid Chromatography) report presents a chromatogram — a graph showing distinct peaks corresponding to different components separated out of a sample. For a peptide purity test, the largest peak should correspond to the intended target molecule, and the analyst calculates what percentage of the total peak area it represents, yielding a purity percentage for that specific sample.
A well-manufactured peptide batch commonly shows purity in the high-90s percent range on this kind of report, though the exact figure varies by compound, synthesis method, and manufacturer.
A Certificate of Analysis (COA) typically bundles the HPLC purity result with additional data, most commonly a mass-spectrometry confirmation of molecular weight and identity. This second data point matters because HPLC purity alone confirms that most of a sample is a single, consistent compound — but not necessarily that the compound is the correct one; mass spectrometry addresses that identity question directly.
Together, these two tests give researchers reasonable confidence both that a sample is largely free of unrelated impurities and that it actually is the peptide the label claims.
Purity and quality can vary meaningfully between production batches, even from the same manufacturer, due to normal variation in synthesis conditions. This is why the research-chemical field generally advises requesting a COA tied to the specific lot number of the vial in hand, rather than accepting a generic or outdated COA that may not reflect the actual batch being purchased.
A COA that cannot be matched to a specific lot number provides meaningfully weaker assurance than one that can.
Because IGF-1 LR3 circulates exclusively as an unregulated research chemical, with no government body verifying manufacturer claims, independent HPLC and mass-spectrometry documentation becomes the primary safeguard available to anyone evaluating a source for this specific compound — a safeguard that carries more weight here than it would for a regulated pharmaceutical with independent regulatory oversight already in place.
This article explains the general concepts involved in this kind of quality verification; it does not provide any IGF-1 LR3-specific purity data.
REVIVE LAB UAE does not sell IGF-1 LR3, and consequently has no COA, HPLC report, or purity claim for this specific compound anywhere on this site. For its actual catalog compounds, REVIVE LAB UAE documents lot-specific Certificates of Analysis as standard practice, reflecting the quality-verification principles described in this article.
This content is educational only, describing how purity verification generally works across the research-peptide field.